Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin vs Vildagliptin for Cardiometabolic Risk and Nephropathy
NCT04485845Phase 4Unknown
- Sponsor
- Cairo University
- Start
- Nov 2019
- Primary completion
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of vildagliptin in type 2 diabetes mellitus (T2DM), metabolic syndrome, diabetic nephropathy (DN), sponsored by Cairo University. Status: unknown.
02
Drugs
vildagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)metabolic syndromediabetic nephropathy (DN)
Beyond the preview
Go deeper on NCT04485845.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04485845.